Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2.

Denisov SS, Ippel JH, Heinzmann ACA, Koenen RR, Ortega-Gomez A, Soehnlein O, Hackeng TM, Dijkgraaf I.

J Biol Chem. 2019 Aug 16;294(33):12370-12379. doi: 10.1074/jbc.RA119.008902. Epub 2019 Jun 24.

2.

68Ga-DOTA-E[c(RGDfK)]2 Positron Emission Tomography Imaging of SHARPIN-Regulated Integrin Activity in Mice.

Siitonen R, Peuhu E, Autio AK, Liljenbäck H, Mattila E, Metsälä O, Käkelä M, Saanijoki T, Dijkgraaf I, Jalkanen S, Ivaska J, Roivainen A.

J Nucl Med. 2019 Mar 8. pii: jnumed.118.222026. doi: 10.2967/jnumed.118.222026. [Epub ahead of print]

PMID:
30850498
3.

SecScan: a general approach for mapping disulfide bonds in synthetic and recombinant peptides and proteins.

Denisov SS, Ippel JH, Mans BJ, Dijkgraaf I, Hackeng TM.

Chem Commun (Camb). 2019 Jan 29;55(10):1374-1377. doi: 10.1039/c8cc08777f.

PMID:
30520894
4.

Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon.

Bucerius J, Dijkgraaf I, Mottaghy FM, Schurgers LJ.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):251-265. doi: 10.1007/s00259-018-4176-z. Epub 2018 Oct 9.

5.

Use of Cyclic Backbone NGR-Based SPECT to Increase Efficacy of Postmyocardial Infarction Angiogenesis Imaging.

Hendrikx G, Hackeng TM, van Gorp R, Bauwens M, Schurgers LJ, Mottaghy FM, Post MJ, Dijkgraaf I.

Contrast Media Mol Imaging. 2017 Oct 24;2017:8638549. doi: 10.1155/2017/8638549. eCollection 2017.

6.

Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation.

von Hundelshausen P, Agten SM, Eckardt V, Blanchet X, Schmitt MM, Ippel H, Neideck C, Bidzhekov K, Leberzammer J, Wichapong K, Faussner A, Drechsler M, Grommes J, van Geffen JP, Li H, Ortega-Gomez A, Megens RT, Naumann R, Dijkgraaf I, Nicolaes GA, Döring Y, Soehnlein O, Lutgens E, Heemskerk JW, Koenen RR, Mayo KH, Hackeng TM, Weber C.

Sci Transl Med. 2017 Apr 5;9(384). pii: eaah6650. doi: 10.1126/scitranslmed.aah6650.

PMID:
28381538
7.

Editorial European Journal of Nuclear Medicine and Molecular Imaging.

Beer AJ, Dijkgraaf I.

Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):284-285. doi: 10.1007/s00259-016-3559-2. No abstract available.

8.

CXCL1 microspheres: a novel tool to stimulate arteriogenesis.

Caolo V, Vries M, Zupancich J, Houben M, Mihov G, Wagenaar A, Swennen G, Nossent Y, Quax P, Suylen D, Dijkgraaf I, Molin D, Hackeng T, Post M.

Drug Deliv. 2016 Oct;23(8):2919-2926. Epub 2015 Dec 10.

PMID:
26651867
9.

Molecular imaging of angiogenesis after myocardial infarction by (111)In-DTPA-cNGR and (99m)Tc-sestamibi dual-isotope myocardial SPECT.

Hendrikx G, De Saint-Hubert M, Dijkgraaf I, Bauwens M, Douma K, Wierts R, Pooters I, Van den Akker NM, Hackeng TM, Post MJ, Mottaghy FM.

EJNMMI Res. 2015 Jan 28;5:2. doi: 10.1186/s13550-015-0081-7. eCollection 2015.

10.

Erratum to: CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space.

Vries MH, Wagenaar A, Verbruggen SE, Molin DG, Dijkgraaf I, Hackeng TH, Post MJ.

Angiogenesis. 2015 Apr;18(2):173. doi: 10.1007/s10456-014-9458-x. No abstract available.

PMID:
25567749
11.

CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space.

Vries MH, Wagenaar A, Verbruggen SE, Molin DG, Dijkgraaf I, Hackeng TH, Post MJ.

Angiogenesis. 2015 Apr;18(2):163-71. doi: 10.1007/s10456-014-9454-1. Epub 2014 Dec 10. Erratum in: Angiogenesis. 2015 Apr;18(2):173. Dijkgraaf, Ingrid [added]; Hackeng, Tilman H [added].

PMID:
25490937
12.

Dimeric [(68)Ga]DOTA-RGD peptide targeting αvβ 3 integrin reveals extracellular matrix alterations after myocardial infarction.

Kiugel M, Dijkgraaf I, Kytö V, Helin S, Liljenbäck H, Saanijoki T, Yim CB, Oikonen V, Saukko P, Knuuti J, Roivainen A, Saraste A.

Mol Imaging Biol. 2014 Dec;16(6):793-801. doi: 10.1007/s11307-014-0752-1.

PMID:
24984688
13.

Synthesis and application of cNGR-containing imaging agents for detection of angiogenesis.

Dijkgraaf I, Van de Vijver P, Dirksen A, Hackeng TM.

Bioorg Med Chem. 2013 Jun 15;21(12):3555-64. doi: 10.1016/j.bmc.2013.04.002. Epub 2013 Apr 13. Review.

PMID:
23643902
14.

Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide.

Dijkgraaf I, Terry SY, McBride WJ, Goldenberg DM, Laverman P, Franssen GM, Oyen WJ, Boerman OC.

Contrast Media Mol Imaging. 2013 May-Jun;8(3):238-45. doi: 10.1002/cmmi.1523.

15.

The chemoselective reactions of tyrosine-containing G-protein-coupled receptor peptides with [Cp*Rh(H2O)3](OTf)2, including 2D NMR structures and the biological consequences.

Albada HB, Wieberneit F, Dijkgraaf I, Harvey JH, Whistler JL, Stoll R, Metzler-Nolte N, Fish RH.

J Am Chem Soc. 2012 Jun 27;134(25):10321-4. doi: 10.1021/ja303010k. Epub 2012 Jun 15.

PMID:
22671299
16.

PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.

Dijkgraaf I, Franssen GM, McBride WJ, D'Souza CA, Laverman P, Smith CJ, Goldenberg DM, Oyen WJ, Boerman OC.

J Nucl Med. 2012 Jun;53(6):947-52. doi: 10.2967/jnumed.111.100891. Epub 2012 May 8.

17.

PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.

Gourni E, Demmer O, Schottelius M, D'Alessandria C, Schulz S, Dijkgraaf I, Schumacher U, Schwaiger M, Kessler H, Wester HJ.

J Nucl Med. 2011 Nov;52(11):1803-10. doi: 10.2967/jnumed.111.098798.

18.

Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4.

Demmer O, Dijkgraaf I, Schumacher U, Marinelli L, Cosconati S, Gourni E, Wester HJ, Kessler H.

J Med Chem. 2011 Nov 10;54(21):7648-62. doi: 10.1021/jm2009716. Epub 2011 Oct 11.

PMID:
21905730
19.

Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method.

Yim CB, van der Wildt B, Dijkgraaf I, Joosten L, Eek A, Versluis C, Rijkers DT, Boerman OC, Liskamp RM.

Chembiochem. 2011 Mar 21;12(5):750-60. doi: 10.1002/cbic.201000639. Epub 2011 Feb 15.

PMID:
21328514
20.

PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides.

Dijkgraaf I, Yim CB, Franssen GM, Schuit RC, Luurtsema G, Liu S, Oyen WJ, Boerman OC.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):128-37. doi: 10.1007/s00259-010-1615-x. Epub 2010 Sep 21.

21.

Molecular imaging of angiogenesis with SPECT.

Dijkgraaf I, Boerman OC.

Eur J Nucl Med Mol Imaging. 2010 Aug;37 Suppl 1:S104-13. doi: 10.1007/s00259-010-1499-9. Review.

22.

Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed "click" cycloaddition and thio acid/sulfonyl azide "sulfo-click" amidation and their in vivo evaluation.

Yim CB, Dijkgraaf I, Merkx R, Versluis C, Eek A, Mulder GE, Rijkers DT, Boerman OC, Liskamp RM.

J Med Chem. 2010 May 27;53(10):3944-53. doi: 10.1021/jm100246m.

PMID:
20411957
23.

Radionuclide imaging of tumor angiogenesis.

Dijkgraaf I, Boerman OC.

Cancer Biother Radiopharm. 2009 Dec;24(6):637-47. doi: 10.1089/cbr.2009.0694. Review.

PMID:
20025543
24.

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression.

Dijkgraaf I, Beer AJ, Wester HJ.

Front Biosci (Landmark Ed). 2009 Jan 1;14:887-99. Review.

PMID:
19273106
25.

Introduction of functional groups into peptides via N-alkylation.

Demmer O, Dijkgraaf I, Schottelius M, Wester HJ, Kessler H.

Org Lett. 2008 May 15;10(10):2015-8. doi: 10.1021/ol800654n. Epub 2008 Apr 12.

PMID:
18407647
26.

Development and application of peptide-based radiopharmaceuticals.

Dijkgraaf I, Boerman OC, Oyen WJ, Corstens FH, Gotthardt M.

Anticancer Agents Med Chem. 2007 Sep;7(5):543-51. Review.

PMID:
17896914
27.

Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes.

Dijkgraaf I, Rijnders AY, Soede A, Dechesne AC, van Esse GW, Brouwer AJ, Corstens FH, Boerman OC, Rijkers DT, Liskamp RM.

Org Biomol Chem. 2007 Mar 21;5(6):935-44. Epub 2007 Jan 29.

PMID:
17340009
28.

Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.

Dijkgraaf I, Liu S, Kruijtzer JA, Soede AC, Oyen WJ, Liskamp RM, Corstens FH, Boerman OC.

Nucl Med Biol. 2007 Jan;34(1):29-35.

PMID:
17210459
29.

Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.

Dijkgraaf I, Kruijtzer JA, Frielink C, Soede AC, Hilbers HW, Oyen WJ, Corstens FH, Liskamp RM, Boerman OC.

Nucl Med Biol. 2006 Nov;33(8):953-61.

PMID:
17127167
30.

Nuclear medicine imaging and therapy of neuroendocrine tumours.

Gotthardt M, Dijkgraaf I, Boerman OC, Oyen WJ.

Cancer Imaging. 2006 Oct 31;6:S178-84.

31.

Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.

Dijkgraaf I, Kruijtzer JA, Frielink C, Corstens FH, Oyen WJ, Liskamp RM, Boerman OC.

Int J Cancer. 2007 Feb 1;120(3):605-10.

32.

Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.

Dijkgraaf I, Kruijtzer JA, Liu S, Soede AC, Oyen WJ, Corstens FH, Liskamp RM, Boerman OC.

Eur J Nucl Med Mol Imaging. 2007 Feb;34(2):267-73. Epub 2006 Aug 15.

PMID:
16909226
33.

Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation.

Janssen M, Frielink C, Dijkgraaf I, Oyen W, Edwards DS, Liu S, Rajopadhye M, Massuger L, Corstens F, Boerman O.

Cancer Biother Radiopharm. 2004 Aug;19(4):399-404.

PMID:
15453954
34.

Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting.

Janssen M, Oyen WJ, Massuger LF, Frielink C, Dijkgraaf I, Edwards DS, Radjopadhye M, Corstens FH, Boerman OC.

Cancer Biother Radiopharm. 2002 Dec;17(6):641-6.

PMID:
12537667
35.

Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

Janssen ML, Oyen WJ, Dijkgraaf I, Massuger LF, Frielink C, Edwards DS, Rajopadhye M, Boonstra H, Corstens FH, Boerman OC.

Cancer Res. 2002 Nov 1;62(21):6146-51.

Supplemental Content

Loading ...
Support Center